Overview

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma

Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
0
Participant gender:
All
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Peripheral stem cell transplantation may allow doctors to give higher doses of chemotherapy drugs and kill more tumor cells. Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy plus peripheral stem cell transplantation followed by surgery and/or radiation therapy in treating young patients who have newly diagnosed advanced neuroblastoma.
Phase:
Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Children's Oncology Group
Collaborator:
National Cancer Institute (NCI)
Treatments:
Carboplatin
Cobalt
Cyclophosphamide
Doxorubicin
Etoposide
Lenograstim
Liposomal doxorubicin
Mesna
Vincristine
Criteria
DISEASE CHARACTERISTICS: Newly diagnosed stage IV neuroblastoma by one of the following:
Histologic verification Demonstration of tumor cell clumps in bone marrow with elevated
urinary catecholamine metabolites Initial presentation with low-stage disease allowed if
followed by progression to stage IV disease

PATIENT CHARACTERISTICS: Age: 1 to 21 Performance status: Not specified Hematopoietic:
(unless bone marrow involvement by tumor) Absolute neutrophil count greater than 1,000/mm3
Platelet count greater than 100,000/mm3 Hepatic: Bilirubin less than 3.0 mg/dL Renal:
Creatinine less than 1.5 mg/dL Creatinine clearance or radionuclide GFR greater than 60
mL/min Cardiovascular: EKG normal Ejection fraction at least 55% by radionuclide MUGA OR
Fractional shortening at least 28% by echocardiogram Other: No other significant organ
dysfunction that precludes study treatment Body weight at least 10 kg Not pregnant or
nursing Effective contraception required of fertile patients

PRIOR CONCURRENT THERAPY: No prior systemic chemotherapy No prior radiotherapy except as
emergency treatment